Momenta Pharmaceuticals, Inc.
(NASDAQ : MNTA)

( )
MNTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.58%62.991.0%$429.08m
AMGNAmgen, Inc. 1.01%240.001.3%$419.59m
BIIBBiogen, Inc. 0.46%288.501.4%$364.64m
ILMNIllumina, Inc. -0.10%328.003.5%$323.24m
VRTXVertex Pharmaceuticals, Inc. -0.78%233.991.9%$273.36m
REGNRegeneron Pharmaceuticals, Inc. 1.32%368.502.6%$220.13m
EXASEXACT Sciences Corp. 0.82%86.6024.0%$198.72m
ITCIIntra-Cellular Therapies, Inc. 0.28%25.509.0%$173.94m
ALXNAlexion Pharmaceuticals, Inc. -0.23%113.012.0%$173.06m
INCYIncyte Corp. -2.30%78.652.5%$135.12m
SRPTSarepta Therapeutics, Inc. -2.43%120.0014.6%$129.81m
AAgilent Technologies, Inc. -0.56%89.621.6%$120.06m
BMRNBioMarin Pharmaceutical, Inc. -0.82%87.554.3%$106.16m
BLUEbluebird bio, Inc. -2.26%95.8214.2%$95.27m
SGENSeattle Genetics, Inc. -0.30%108.676.1%$90.33m

Company Profile

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.